Patents by Inventor Shan-Shue Wang

Shan-Shue Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10710002
    Abstract: A method of extracting nutrients from a plant includes the steps of: pulverizing a water soluble nutrient-based plant part of a first plant material of the plant so as to form a first pulverized plant part; pulverizing a lipid soluble nutrient-based plant part of a second plant material of the plant so as to form a second pulverized plant part; subjecting the first pulverized plant part to a distillation so as to obtain a distillate and a first residue that contains a water soluble nutrient; and immersing the second pulverized plant part in the distillate to form a first mixture followed by distillation of the first mixture, so as to obtain a second residue that contains a lipid soluble nutrient.
    Type: Grant
    Filed: January 17, 2017
    Date of Patent: July 14, 2020
    Assignee: NUECOLOGY BIOMEDICAL INC.
    Inventors: Chung-Chin Sun, Yeuh-Hui Lin, Shan-Shue Wang
  • Publication number: 20200085747
    Abstract: A method for blood plasma protein activity preservation is provided. The method comprises the steps of mixing blood plasma with two or more protectants selected from the group consisting of triglyceride, glycerol, propylene glycol, alanine, serine, glycine, alginate, and sucrose to obtain a mixture; and lyophilizing the mixture.
    Type: Application
    Filed: December 21, 2016
    Publication date: March 19, 2020
    Inventors: Cheng-Yao SU, Chung Chin SUN, Shan Shue WANG
  • Publication number: 20170216739
    Abstract: A method of extracting nutrients from a plant includes the steps of: pulverizing a water soluble nutrient-based plant part of a first plant material of the plant so as to form a first pulverized plant part; pulverizing a lipid soluble nutrient-based plant part of a second plant material of the plant so as to form a second pulverized plant part; subjecting the first pulverized plant part to a distillation so as to obtain a distillate and a first residue that contains a water soluble nutrient; and immersing the second pulverized plant part in the distillate to form a first mixture followed by distillation of the first mixture, so as to obtain a second residue that contains a lipid soluble nutrient.
    Type: Application
    Filed: January 17, 2017
    Publication date: August 3, 2017
    Inventors: Chung-Chin SUN, Yeuh-Hui LIN, Shan-Shue WANG
  • Patent number: 5981577
    Abstract: A compound of formula I, ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.1 ', R.sub.2 ', and R.sub.3 ' are independently the same or different and each represent hydrogen, hydroxy, or lower alkoxy, or any vicinal two of R.sub.1, R.sub.2, R.sub.3, R.sub.1 ', R.sub.2 ', and R.sub.3 ' combined together represent --O--(CH.sub.2).sub.n --O--, wherein n=1 or 2; R.sub.4 represents methylene or halomethyl; and X.sub.1, X.sub.2, X.sub.3, and X.sub.4 are independently the same or different and each represent hydrogen or halogen; or a pharmaceutically acceptable salt thereof. Also disclosed are a pharmaceutical composition that contains an effective amount of a compound of formula I together with a pharmaceutically acceptable excipient, and a method of treating cancer that involves the administration of an effective amount of the compound of formula I to a patient in need thereof.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: November 9, 1999
    Assignee: Development Center for Biotechnology
    Inventors: Shan-Yen Chou, Shan-Shue Wang, Han-Jung Tsai, Shyh-Fong Chen, Hou Ku
  • Patent number: 5942546
    Abstract: A compound of the formula: ##STR1## wherein X is arylene, heteroarylene, fused arylene, fused heteroarylene, or deleted; Y is sulfonyl, --O--, or deleted; R.sub.1 is aryl, heteroaryl, fused aryl, or fused heteroaryl; R.sub.2 is H, lower alkyl, lower alkoxy, halo, nitro, cyano, haloalkyl, hydroxyl, carboxyl, amido, amino, or aminoalkyl; or a salt thereof are disclosed. Also disclosed are a pharmaceutical composition which contains an excipient and an effective amount of a compound of the above formula and a method of treating cancer which involves the administration of an effective amount of such a compound to a patient in need thereof.
    Type: Grant
    Filed: November 20, 1997
    Date of Patent: August 24, 1999
    Assignee: Development Center for Biotechnology
    Inventors: Ji-Wang Chern, Yu-Ling Leu, Shan-Shue Wang, Chin-Fen Lee, Shih-Chung Hsu
  • Patent number: 5886185
    Abstract: A series of novel polyamine-linked acridine dimers and derivatives thereof are described. The polyamine-linked acridine dimers and derivatives are potential anti-cancer agents.
    Type: Grant
    Filed: November 20, 1997
    Date of Patent: March 23, 1999
    Assignee: Development Center for Biotechnoloy
    Inventors: Shan-Yen Chou, Shan-Shue Wang, Chin-Fen Lee, Wei-Kun Yin, Shyh-Fong Chen
  • Patent number: 5840991
    Abstract: The invention relates to novel compounds of formula (I) ##STR1## wherein R.sub.1 represents hydrogen, hydroxy or alkoxy;R.sub.2, R.sub.3, R.sub.4 and R.sub.5 may be hydrogen or alkyl; andn is 0,1 or 2;and the pharmaceutically acceptable salts thereof.The invention also relates to the processes for preparing the compounds of formula (I), and the pharmaceutical compositions containing them, and their use as a low density lipoprotein peroxidation inhibitors, anti-atherosclerotic agents and/or antihyperlipidemic agents.
    Type: Grant
    Filed: September 17, 1997
    Date of Patent: November 24, 1998
    Assignee: Development Center for Biotechnology
    Inventors: Feng-Wen Yeng, Shan-Shue Wang, Jaw-Yuh Chiu, Chin-Fen Lee, Chia-Lin J. Wang